Evidence map›Paper›PMID 23937701›Full record

ArticleTropical medicine & international health : TM & IH2013

Detectable urogenital schistosome DNA and cervical abnormalities 6 months after single-dose praziquantel in women with Schistosoma haematobium infection.

Jennifer A Downs, Rodrick Kabangila, Jaco J Verweij, Hyasinta Jaka, Robert N Peck, Samuel E Kalluvya, John M Changalucha, Warren D Johnson, Lisette van Lieshout, Daniel W Fitzgerald

Open access · bronzeAbstract read
In one paragraph

Article in Tropical medicine & international health : TM & IH, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Open forum infectious diseases · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Impact of Endemic Infections on HIV Susceptibility in Sub-Saharan Africa.Tropical diseases, travel medicine and vaccines · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Jennifer A DownsDepartment of Medicine, Weill Cornell Medical College, New York, NY, USA.
Rodrick KabangilaDepartment of Medicine, Bugando Medical Centre, Mwanza, Tanzania.
Jaco J VerweijDepartment of Parasitology, Leiden University Medical Centre, Leiden, The Netherlands.
Hyasinta JakaDepartment of Medicine, Bugando Medical Centre, Mwanza, Tanzania.
Robert N PeckDepartment of Medicine, Weill Cornell Medical College, New York, NY, USA.
Samuel E KalluvyaDepartment of Medicine, Bugando Medical Centre, Mwanza, Tanzania.
John M ChangaluchaNational Institute for Medical Research - Mwanza Research Centre, Mwanza, Tanzania.
Warren D JohnsonDepartment of Medicine, Weill Cornell Medical College, New York, NY, USA.
Lisette van LieshoutDepartment of Parasitology, Leiden University Medical Centre, Leiden, The Netherlands.
Daniel W FitzgeraldDepartment of Medicine, Weill Cornell Medical College, New York, NY, USA.
Bugando Medical Centre · TZCornell University · USLeiden University · NLLeiden University Medical Center · NLNational Institute for Medical Research · TZ

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024996 · NCRR · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2007 to 2011
$49.6M
Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
T32: Pathogenesis of Infectious Diseases Training ProgramT32AI007613 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROY M. GULICK · 1999 to 2026
$8.8M
Global Health Research Training in HIV and TuberculosisK24AI098627 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI FITZGERALD, DANIEL W · 2012 to 2022
$1.8M
AHRQ HHS T32 HS000066NCATS NIH HHS UL1 TR000457NCRR NIH HHS UL1 RR024996NIAID NIH HHS K24 AI098627NIAID NIH HHS T32 AI007613
6 · The paper itself

Abstract

We explored response to single-dose praziquantel therapy in a cohort of 33 women with Schistosoma haematobium infection in rural Mwanza, Tanzania. Women with S. haematobium infection confirmed both by eggs in urine and by polymerase chain reaction (PCR) received single-dose praziquantel and treatment of concomitant sexually transmitted infections. Macroscopic cervical abnormalities were also quantified. After 6 months, microscopically detectable egg excretion was eliminated, but 8 of 33 women (24%) were persistently positive for S. haematobium by PCR, and 11 (33%) had cervical abnormalities potentially attributable to schistosomiasis. This suggests that praziquantel treatment more frequently than every 6 months may be necessary for complete elimination of the parasite and prevention of genital tissue pathology. This aggressive therapy may in turn play a key role decreasing HIV susceptibility in millions of people living in regions in which S. haematobium is endemic.

Indexed as

AdolescentAdultAnimalsCervix UteriCohort StudiesEndemic DiseasesFemaleHIV InfectionsHumansMiddle AgedPolymerase Chain ReactionPraziquantelSchistosoma haematobiumSchistosomiasis haematobiaTanzaniaTime FactorsPraziquantelfemale urogenital schistosomiasispolymerase chain reactionpraziquantelSchistosoma haematobiumTanzania

Identifiers

PMID23937701
PMCPMC4014060
OpenAlexW2055151500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.